Category

Cohort News

Cyted Health Expands US Presence with First Patients Enrolled in DETECT-ME Clinical Validation Study

//
Categories
WILMINGTON, Del. and CAMBRIDGE, England, March 25, 2025 /PRNewswire/ — Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces the enrollment of the first patient in the DETECT-ME clinical validation study (NCT06803927). The study evaluates Cyted Health’s advanced molecular assays using esophageal cells...
Read More →

Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom

//
Categories
For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic assessments NEW YORK–(BUSINESS WIRE)–Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software...
Read More →